INTEGRATED BIOPHARMA INC (INBP) Gross margin 2017–2025
INTEGRATED BIOPHARMA INC (INBP) gross margin by fiscal year — reported gross profit divided by reported revenue.
10.2%FY2025 · since FY2017: 14.2% → 10.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.2% | +2.5 pp |
| FY2024 | 7.7% | -0.3 pp |
| FY2023 | 8.0% | -3.6 pp |
| FY2022 | 11.6% | -3.3 pp |
| FY2021 | 14.9% | +2.2 pp |
| FY2020 | 12.7% | +0.3 pp |
| FY2019 | 12.4% | +1.0 pp |
| FY2018 | 11.4% | -2.8 pp |
| FY2017 | 14.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice